Epivios GmbH, a Düsseldorf, Germany-based developer of molecular diagnostic cancer tests. Led by Nicole Groth and Dr Simeon Santourlidis, Epivios was founded in 2011 as a spin-off of the Heinrich Heine University of Düsseldorf. Its interdisciplinary team, comprising doctors and biologists, has been working since 2009 on innovative epigenetic procedures for cancer diagnosis. The company’s epigenetic platform technology includes a new kind of standardization tool that allows the comparison of samples with differing genetic constitution for the first time. Epivios´s new procedure also analyzes sequences, which spread across the entire genome.
Funding Rounds (1) - undisclosedUpdate
|Jul 11, 2012||FinSMEs - FinSMEs|
Düsseldorf Moorenstr. 5,